Your browser doesn't support javascript.
Bispecific antiviral neutralizing antibodies are twice as nice.
Crowe, James E.
  • Crowe JE; Vanderbilt Vaccine Center and Departments of Pediatrics, Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
Nat Immunol ; 23(3): 346-347, 2022 03.
Article in English | MEDLINE | ID: covidwho-1751736
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Bispecific / COVID-19 Limits: Humans Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41590-022-01147-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Bispecific / COVID-19 Limits: Humans Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41590-022-01147-9